Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

DeepDyve requires Javascript to function. Please enable Javascript on your browser to continue.

Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study

Antonia, Scott; Goldberg, Sarah B; Balmanoukian, Ani; Chaft, Jamie E; Sanborn, Rachel E;

The Lancet Oncology – Feb 5, 2016

Download PDF

Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study

Antonia, Scott; Goldberg, Sarah B; Balmanoukian, Ani; Chaft, Jamie E; Sanborn, Rachel E;

The Lancet Oncology – Feb 5, 2016

Loading next page...

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher: Unpaywall
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(15)00544-6
Publisher site: See Article on Publisher Site

There are no references for this article.